Sponsor study identifier
Secondary identifiers
OTHER · SWOG
NIH
observational
0
1 country
1
Study Start
October 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
February 2010
Actual (reported)Study Completion
February 2010
Actual (reported)RATIONALE: Gathering information over time from imaging and laboratory tests of women receiving bisphosphonates for breast cancer may help doctors learn more about long-term bone quality and plan the best treatment. Tetracycline hydrochloride and demeclocycline hydrochloride can mark the new growth of the bone, so it may be seen better under a microscope. PURPOSE: This clinical trial is studying long-term bone quality in women with breast cancer enrolled on clinical trial SWOG-S0307.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2010
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2008
Date type not reportedThis date has not been verified as actual or estimated.
April 1, 2009
Actual (reported)April 2, 2009
Actual (reported)February 2010
Actual (reported)February 2010
Actual (reported)Change in bone quality after long-term high-dose bisphosphonates as measured by histomorphometry, mineralization density, micro-computed tomography, and biomechanics of bone biopsy samples
Comparison of the potency of bisphosphonates as measured by changes in bone quality in each treatment group
Correlations among measures of bone formation, structure, mineralization, and strength
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
University Cancer Center at University of Washington Medical Center
Seattle, Washington, 98195-6043, United States
Dawn Hershman, MD
Herbert Irving Comprehensive Cancer Center
0 participants (actual enrollment reported by the registry).
First Submitted
April 1, 2009
First Posted
April 2, 2009
Study Start
October 2008
Date type not reportedThis date has not been verified as actual or estimated.
Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Primary Completion
February 2010
Actual (reported)Study Completion
February 2010
Actual (reported)Last Updated
April 10, 2013
Record last verified: 2013-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: